All In MedTech

Device Trial Radar · NCT07220330

An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations

Last checked: Nov 19, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

700

Planned (sponsor's estimate)

Start

Jan 15, 2025

Primary completion

Oct 2026

Study completion Oct 2026

Sponsor

Lead sponsor
Qbtech ABNot on our public-company list
Sponsor type
Industry
First posted
Oct 23, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 6 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate QbMobile ability to collect and provide accurate and objective data which can be used to facilitate assessment and treatment procedures for ADHD in a clinical setting as well as remotely.

Conditions

  • No History of ADHD
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Healthy Volunteer

Interventions

  • QbMobileDevice

    QbMobile is a software application that can be installed on a smartphone device used to measure activity, attention, impulsivity, and movement patterns in participants over a two-day period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Standardized QbMobile Scores of the four parameters: Attention, Impulsivity, Activity, and Movement Patterns.Time frame: 10-minute testing period

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Prodigy Psychiatric Group

    San Jose, California

  • Bokhari Medical Consortium

    Largo, Florida

  • Nona Pediatric Center

    Orlando, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.